Stockscreener 앱 받기
10.12
3.58%
-0.375
Erasca Inc 주식(ERAS)의 최신 뉴스
Guggenheim raises Erasca stock price target to $12 on RAS inhibitor progress - Investing.com UK
Erasca stock price target raised to $15 from $11 at H.C. Wainwright - Investing.com
Revolution Medicines, Erasca And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why Is Cancer Drug Developer Erasca Stock Trading Lower Monday? - Benzinga
Morgan Stanley Raises Price Target on Erasca to $10 From $4, Keeps Equalweight Rating - marketscreener.com
Fundamentals Check: How does Erasca Inc perform in inflationary periods2025 Price Momentum & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Erasca completes $258.8 million public offering of common stock By Investing.com - Investing.com South Africa
Investor Mood: Should I average down on Erasca Inc stock2025 Major Catalysts & Stock Portfolio Risk Control - baoquankhu1.vn
Erasca completes $258.8 million public offering of common stock - Investing.com
Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - manilatimes.net
Erasca prices $225M stock offering at $10 per share - MSN
Erasca stock hits 52-week high at 10.46 USD By Investing.com - Investing.com Nigeria
Erasca Announces Major Underwritten Public Equity Offering - TipRanks
Erasca, Inc. Announces Upsized Public Offering of Common Stock - TradingView
Erasca raises $225M to sharpen RAS oncology focus - BioWorld MedTech
Latham & Watkins Advises Erasca in Upsized US$225 Million Offering of Common Stock - Latham & Watkins LLP
A trio of biotechs targets $500M+ offerings - Endpoints News
Erasca stock hits 52-week high at 10.46 USD - Investing.com
Top 2 Tech Stocks That Are Ticking Portfolio Bombs - Benzinga
ERAS Stock Surges 61% With A 6-day Winning Spree On HC Wainwright’s $11 Target - Trefis
Erasca plans to raise $150 million in public stock offering By Investing.com - Investing.com Australia
Erasca Announces Pricing of Upsized Public Offering of Common Stock - The Manila Times
Erasca, Inc. Announces Pricing of $225 Million Public Offering of Common Stock - Quiver Quantitative
Cancer drug developer Erasca raises $225M in stock sale - Stock Titan
Erasca (ERAS) soars 42% on bullish rating, PT upgrade - MSN
Top 2 Industrials Stocks That May Collapse In Q1 - Benzinga
Netflix, Erasca, Kraft Heinz And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Erasca Stock Pre-Market (-8.3%): Proposed $150M Stock Offering - Trefis
Erasca Announces $150 Million Public Offering; Stock Down - Nasdaq
Erasca Stock Pre-Market (-8.3%) : Announces $150M Public Stock Offering - Trefis
Erasca plans $150M public stock offering - MSN
Erasca reports preliminary year-end cash and securities of $341.8 million - Investing.com Nigeria
Erasca stock falls after announcing $150 million public offering - Investing.com
Erasca stock falls after announcing $150 million public offering By Investing.com - Investing.com Nigeria
Erasca announces proposed public offering of $150 million of common stock - marketscreener.com
Erasca (ERAS) Stock Slides After The Bell: Here's Why - Benzinga
Erasca (ERAS) Announces $150M Public Offering to Fund Cancer Research - Intellectia AI
Erasca, Inc. Announces Proposed Public Offering of $150 Million in Common Stock - Quiver Quantitative
Erasca Announces Proposed Public Offering of $150 Million of Common Stock - The Manila Times
Cancer drug developer Erasca plans $150M stock sale to fund R&D - Stock Titan
Erasca (ERAS) Soars 42% on Bullish Rating, PT Upgrade - Finviz
Erasca (ERAS) touches 3-year high as 4 analysts go bullish; gets 267% PT hike - MSN
Do Early ERAS-0015 Data Reframe Erasca’s (ERAS) Ambitions in RAS-Targeted Oncology? - simplywall.st
Erasca stock surges 42% in a week: Here's what you should know - MSN
2.70%
3.24%
자본화:
|
볼륨(24시간):